Royal Bank of Canada’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.62M Buy
116,187
+14,203
+14% +$931K ﹤0.01% 2034
2025
Q1
$7.2M Buy
101,984
+325
+0.3% +$22.9K ﹤0.01% 1777
2024
Q4
$6.68M Buy
101,659
+14,574
+17% +$958K ﹤0.01% 1843
2024
Q3
$6.15M Buy
87,085
+1,342
+2% +$94.7K ﹤0.01% 1863
2024
Q2
$5.69M Sell
85,743
-24,034
-22% -$1.59M ﹤0.01% 1867
2024
Q1
$7.46M Sell
109,777
-9,350
-8% -$635K ﹤0.01% 1690
2023
Q4
$7.36M Buy
119,127
+7,626
+7% +$471K ﹤0.01% 1675
2023
Q3
$6.58M Sell
111,501
-16,905
-13% -$997K ﹤0.01% 1620
2023
Q2
$7.67M Sell
128,406
-8,994
-7% -$537K ﹤0.01% 1552
2023
Q1
$8.03M Buy
137,400
+7,497
+6% +$438K ﹤0.01% 1520
2022
Q4
$8.06M Sell
129,903
-7,638
-6% -$474K ﹤0.01% 1534
2022
Q3
$7.77M Buy
137,541
+14,178
+11% +$801K ﹤0.01% 1501
2022
Q2
$7.88M Sell
123,363
-11,496
-9% -$734K ﹤0.01% 1519
2022
Q1
$8.73M Buy
134,859
+7,485
+6% +$485K ﹤0.01% 1582
2021
Q4
$8.48M Buy
127,374
+13,194
+12% +$878K ﹤0.01% 1715
2021
Q3
$6.97M Sell
114,180
-37,356
-25% -$2.28M ﹤0.01% 1806
2021
Q2
$9.38M Buy
151,536
+3,543
+2% +$219K ﹤0.01% 1648
2021
Q1
$8.76M Buy
147,993
+27,861
+23% +$1.65M ﹤0.01% 1632
2020
Q4
$7.19M Buy
120,132
+33,897
+39% +$2.03M ﹤0.01% 1679
2020
Q3
$4.7M Sell
86,235
-95,586
-53% -$5.21M ﹤0.01% 1780
2020
Q2
$9.33M Buy
181,821
+103,095
+131% +$5.29M ﹤0.01% 1352
2020
Q1
$3.53M Sell
78,726
-65,328
-45% -$2.93M ﹤0.01% 1783
2019
Q4
$7.69M Sell
144,054
-58,656
-29% -$3.13M ﹤0.01% 1537
2019
Q3
$9.45M Buy
202,710
+72,417
+56% +$3.38M ﹤0.01% 1369
2019
Q2
$6.55M Sell
130,293
-4,185
-3% -$210K ﹤0.01% 1593
2019
Q1
$6.9M Buy
134,478
+49,809
+59% +$2.56M ﹤0.01% 1504
2018
Q4
$3.97M Buy
84,669
+9,219
+12% +$432K ﹤0.01% 1778
2018
Q3
$4.22M Sell
75,450
-58,860
-44% -$3.29M ﹤0.01% 1879
2018
Q2
$6.78M Sell
134,310
-23,463
-15% -$1.18M ﹤0.01% 1506
2018
Q1
$7.76M Sell
157,773
-25,425
-14% -$1.25M ﹤0.01% 1435
2017
Q4
$9.43M Buy
183,198
+100,959
+123% +$5.2M ﹤0.01% 1351
2017
Q3
$4.29M Buy
82,239
+2,952
+4% +$154K ﹤0.01% 1708
2017
Q2
$4.1M Sell
79,287
-45,993
-37% -$2.38M ﹤0.01% 1691
2017
Q1
$6.3M Sell
125,280
-54,228
-30% -$2.73M ﹤0.01% 1468
2016
Q4
$8.46M Buy
179,508
+58,779
+49% +$2.77M ﹤0.01% 1323
2016
Q3
$6.02M Sell
120,729
-31,989
-21% -$1.59M ﹤0.01% 1462
2016
Q2
$7.35M Sell
152,718
-52,911
-26% -$2.55M ﹤0.01% 1360
2016
Q1
$9.39M Sell
205,629
-143,115
-41% -$6.53M 0.01% 1209
2015
Q4
$18.8M Buy
348,744
+60,267
+21% +$3.25M 0.01% 873
2015
Q3
$14.2M Sell
288,477
-49,215
-15% -$2.43M 0.01% 805
2015
Q2
$19.7M Buy
337,692
+63,972
+23% +$3.73M 0.01% 748
2015
Q1
$15.7M Buy
273,720
+51,054
+23% +$2.93M 0.01% 851
2014
Q4
$11.2M Buy
222,666
+17,814
+9% +$899K 0.01% 978
2014
Q3
$9.58M Sell
204,852
-12,156
-6% -$569K 0.01% 1030
2014
Q2
$9.77M Buy
217,008
+150
+0.1% +$6.76K 0.01% 1056
2014
Q1
$9.16M Buy
216,858
+6,717
+3% +$284K 0.01% 1046
2013
Q4
$8.27M Sell
210,141
-2,259
-1% -$88.9K 0.01% 1063
2013
Q3
$7.53M Buy
212,400
+1,626
+0.8% +$57.7K 0.01% 1038
2013
Q2
$7M Buy
+210,774
New +$7M 0.01% 999